ZyVersa Therapeutics, Inc.
ZVSA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001859007
No open-market purchases or sales by ZyVersa Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in ZyVersa Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +4 vs. Q1 2022
- Shares held
- 6.26M
- +679.9K (+12.2%) vs. Q1 2022
- Total value
- $62.2M
- +$6.75M (+12.2%) vs. Q1 2022
- New holders
- 7
- 5 more added
- Sold out
- 3
- 3 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZVSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $1 |
| Q2 2025 | 6 | $44.7K |
| Q1 2025 | 7 | $43.9K |
| Q4 2024 | 8 | $86.2K |
| Q3 2024 | 6 | $7.22K |
| Q2 2024 | 4 | $38.7K |
| Q1 2024 | 8 | $84.9K |
| Q4 2023 | 6 | $181.4K |
| Q3 2023 | 12 | $161.8K |
| Q2 2023 | 11 | $73.4K |
| Q1 2023 | 6 | $273.5K |
| Q4 2022 | 2 | $123.9K |
| Q3 2022 | 29 | $73.3M |
| Q2 2022 | 25 | $62.2M |
| Q1 2022 | 21 | $55.4M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding ZyVersa Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | 700,000 | $6.95M | 0.07% | 00.0% | Unchanged |
| Cohanzick Management, LLC | 700,000 | $6.95M | 1.96% | 00.0% | Unchanged |
| RiverPark Advisors, LLC | 700,000 | $6.95M | 2.20% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 584,280 | $5.80M | 0.08% | +110,000+23.2% | Added |
| Context Capital Management, LLC | 493,972 | $4.91M | 0.35% | −6,028−1.2% | Reduced |
| D. E. Shaw & Co., Inc. | 386,970 | $3.84M | 0.01% | +233,334+151.9% | Added |
| MMCAP International Inc. SPC | 370,000 | $3.67M | 0.29% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 365,613 | $3.63M | 0.05% | +38,900+11.9% | Added |
| Kim, LLC | 350,000 | $3.48M | 0.17% | +350,000 | New |
| Periscope Capital Inc. | 292,305 | $2.90M | 0.08% | +280,687+2,416.0% | Added |
| CVI Holdings, LLC | 249,900 | $2.48M | 0.18% | 00.0% | Unchanged |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 200,000 | $1.99M | 0.02% | 00.0% | Unchanged |
| CNH Partners LLC | 183,093 | $1.82M | 0.04% | −2,215−1.2% | Reduced |
| Whitebox Advisors LLC | 176,900 | $1.76M | 0.06% | 00.0% | Unchanged |
| Barclays PLC | 138,629 | $1.38M | 0.00% | +138,629 | New |
| Janus Henderson Group PLC | 105,000 | $1.04M | 0.00% | 00.0% | Unchanged |
| Glazer Capital, LLC | 83,739 | $832.0K | 0.02% | +12,818+18.1% | Added |
| Cubist Systematic Strategies, LLC | 52,511 | $521.0K | 0.00% | +52,511 | New |
| Polar Asset Management Partners Inc. | 50,000 | $496.0K | 0.01% | +50,000 | New |
| Karpus Management, Inc. | 43,225 | $429.0K | 0.01% | −775−1.8% | Reduced |
| EHP Funds Inc. | 17,126 | $170.0K | 0.03% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 12,000 | $119.0K | 0.04% | 00.0% | Unchanged |
| BlackRock Inc. | 5,000 | $50.0K | 0.00% | +5,000 | New |
| Ancora Advisors, LLC | 2,000 | $20.0K | 0.00% | +2,000 | New |
| Clear Street LLC | 87 | $1.00K | 0.00% | +87 | New |
| Spring Creek Capital LLC | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| Mizuho Securities USA LLC | 0 | $0 | 0.00% | −185,000−100.0% | Sold out |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |